Enfusion share price today
(NASDAQ: ENFN)

Name: Enfusion Share Price Today (NASDAQ: ENFN) - Enfusion Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Enfusion share price is $11.11 & ₹960.90 as on 23 Jan 2025, 20.26 hrs IST

$11.11

Market is closed - opens 8 PM, 23 Jan 2025

View live Enfusion share price in Dollar and Rupees. Guide to invest in Enfusion stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Enfusion, along with analyst recommendations, forecasts, and comprehensive financials.

Enfusion share price movements

Today's Low: $11.06
Today's High: $11.20
$11.11
0.45%
Downside
Day's Volatility :1.25%
Upside
0.8%
52 Weeks Low: $7.52
52 Weeks High: $11.38
$11.11
32.31%
Downside
52 Weeks Volatility :33.89%
Upside
2.33%

Enfusion Returns

Period	Enfusion Inc	Sector (Technology)	Index (Russel 2000)
3 Months	23.17%	5.7%	0.0%
6 Months	17.32%	7.2%	0.0%
1 Year	28.0%	19.6%	0.0%
3 Years	-17.7%	56.4%	-11.0%

Enfusion Key Statistics

in dollars & INR

Previous Close	$11.11
Open	$11.16
Today's High	$11.14
Today's Low	$11.06
Market Capitalization	$1.1B
Today's Volume	$847.1K
52 Week High	$11.375
52 Week Low	$7.52
Revenue TTM	$195.2M
EBITDA	$18.5M
Earnings Per Share (EPS)	$0.04
PE Ratio	277.75
Profit Margin	1.7%
Quarterly Earnings Growth YOY	-0.27%
Return On Equity TTM	5.48%

How to invest in Enfusion Stock (ENFN) from India?

It is very easy for Indian residents to invest directly in Enfusion from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Enfusion stock in both Indian Rupees (INR) and US Dollars (USD). Search for Enfusion or ENFN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Enfusion or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Enfusion shares which would translate to 0.078 fractional shares of Enfusion as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Enfusion, in just a few clicks!

Returns in Enfusion for Indian investors in Rupees

Investment Value

₹1,00,000

Enfusion investment value today

Current value as on today

₹1,32,050

Returns

₹32,050

(+32.05%)

Returns from Enfusion Stock

₹27,995 (+28%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Enfusion

85%

Period: Oct 24, 2024 to Jan 22, 2025. Change in 30 Days versus previous period

Search volume for Enfusion on INDmoney from India has grown in the last 30 days as on Jan 23, 2025. 85% more investors are searching Enfusion in the last 30 days versus the previous period.

Global Institutional Holdings in Enfusion

ICONIQ Capital, LLC
14.88%
Brown Capital Management, LLC
7.64%
Hillhouse Capital Advisors, Ltd.
5.27%
Vanguard Group Inc
4.26%
BlackRock Inc
3.43%
Ararat Capital Management, LP
2.73%

Analyst Recommendation on Enfusion

Sell

23%Buy

30%Hold

46%Sell

Based on 13 Wall street analysts offering stock ratings for Enfusion(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Enfusion

What analysts predicted

Downside of 2.99%

Target:

$10.78

Current:

$11.11

Insights on Enfusion

Price Movement
In the last 3 months, ENFN stock has moved up by 25.7%
Increasing Revenue
Revenue is up for the last 17 quarters, 19.78M → 51.16M (in $), with an average increase of 5.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 1.82M → 1.41M (in $), with an average decrease of 22.5% per quarter
ENFN vs NOW (1 yr)
In the last 1 year, Servicenow, Inc. has given 49.3% return, outperforming this stock by 25.4%
ENFN vs NOW (3 yr)
In the last 3 years, Servicenow, Inc. has given 121.6% return, outperforming this stock by 140.7%
Price to Sales
ForENFN every $1 of sales, investors are willing to pay $5.2, whereas for Servicenow, Inc., the investors are paying $22.1 for every $1 of sales.

Enfusion Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$59.0M	-
Net Income	$12.7M	-
Net Profit Margin	21.44%	-

	FY20	Y/Y Change
Revenue	$79.6M	↑ 34.79%
Net Income	$4.1M	↓ 67.91%
Net Profit Margin	5.1%	↓ 16.34%

	FY21	Y/Y Change
Revenue	$111.7M	↑ 40.39%
Net Income	$-282.2M	↓ 7050.06%
Net Profit Margin	-252.68%	↓ 257.78%

	FY22	Y/Y Change
Revenue	$150.3M	↑ 34.6%
Net Income	$-13.3M	↓ 95.3%
Net Profit Margin	-8.82%	↑ 243.86%

	FY23	Y/Y Change
Revenue	$174.5M	↑ 16.09%
Net Income	$6.0M	↓ 145.43%
Net Profit Margin	3.45%	↑ 12.27%

	Q2 FY23	Q/Q Change
Revenue	$42.7M	↑ 4.27%
Net Income	$629.0K	↓ 86.6%
Net Profit Margin	1.47%	↓ 9.99%

	Q3 FY23	Q/Q Change
Revenue	$44.4M	↑ 3.83%
Net Income	$1.8M	↑ 190.62%
Net Profit Margin	4.12%	↑ 2.65%

	Q4 FY23	Q/Q Change
Revenue	$46.5M	↑ 4.8%
Net Income	$623.0K	↓ 65.92%
Net Profit Margin	1.34%	↓ 2.78%

	Q1 FY24	Q/Q Change
Revenue	$48.1M	↑ 3.37%
Net Income	$-539.0K	↓ 186.52%
Net Profit Margin	-1.12%	↓ 2.46%

	Q2 FY24	Q/Q Change
Revenue	$49.5M	↑ 2.92%
Net Income	$1.8M	↓ 438.78%
Net Profit Margin	3.69%	↑ 4.81%

	Q3 FY24	Q/Q Change
Revenue	$51.2M	↑ 3.46%
Net Income	$1.4M	↓ 22.51%
Net Profit Margin	2.77%	↓ 0.92%

	FY19	Y/Y Change
Profit	$42.1M	-

	FY20	Y/Y Change
Profit	$58.2M	↑ 38.37%

	FY21	Y/Y Change
Profit	$79.9M	↑ 37.19%

	FY22	Y/Y Change
Profit	$103.2M	↑ 29.3%

	FY23	Y/Y Change
Profit	$116.9M	↑ 13.22%

	Q2 FY23	Q/Q Change
Profit	$28.5M	↑ 3.05%

	Q3 FY23	Q/Q Change
Profit	$29.9M	↑ 4.69%

	Q4 FY23	Q/Q Change
Profit	$30.9M	↑ 3.39%

	Q1 FY24	Q/Q Change
Profit	$31.9M	↑ 3.29%

	Q2 FY24	Q/Q Change
Profit	$33.5M	↑ 5.07%

	Q3 FY24	Q/Q Change
Profit	$34.8M	↑ 3.98%

	FY19	Y/Y Change
Operating Cash Flow	$12.3M	-
Investing Cash Flow	$-4.4M	-
Financing Cash Flow	$-7.5M	-

	FY20	Y/Y Change
Operating Cash Flow	$1.7M	↓ 86.47%
Investing Cash Flow	$-5.1M	↑ 14.43%
Financing Cash Flow	$11.6M	↓ 253.28%

	FY21	Y/Y Change
Operating Cash Flow	$-318.0K	↓ 119.1%
Investing Cash Flow	$-8.0M	↑ 58.13%
Financing Cash Flow	$58.8M	↑ 409.12%

	FY22	Y/Y Change
Operating Cash Flow	$14.2M	↓ 4551.57%
Investing Cash Flow	$-7.9M	↓ 1.04%
Financing Cash Flow	$-8.0M	↓ 113.52%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$6.0M	↑ 551.3%
Investing Cash Flow	$-2.2M	↓ 12.98%
Financing Cash Flow	$-30.8M	↑ 385.47%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$12.1M	↑ 101.16%
Investing Cash Flow	$-2.6M	↑ 17.49%
Financing Cash Flow	$-5.3M	↓ 82.79%

Enfusion Technicals Summary

Sell

Neutral

Buy

Enfusion is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Enfusion Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Enfusion Inc	5.01%	17.32%	28.0%	-17.7%	-43.92%
Shopify Inc.	-3.46%	78.95%	31.76%	13.34%	135.8%
Servicenow, Inc.	1.77%	35.76%	47.39%	113.98%	265.75%
Intuit Inc.	-5.21%	-2.34%	-3.85%	14.4%	115.56%
Uber Technologies, Inc.	9.9%	3.16%	6.37%	86.93%	86.83%
Salesforce Inc	-3.43%	29.67%	20.13%	49.14%	84.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Enfusion Inc	277.75	277.75	NA	0.21	0.05	0.06	NA	0.75
Shopify Inc.	110.02	110.02	1.12	1.53	0.15	0.06	NA	7.05
Servicenow, Inc.	170.58	170.58	2.9	13.9	0.16	0.05	NA	45.03
Intuit Inc.	59.5	59.5	1.83	19.29	0.17	0.08	0.01	65.78
Uber Technologies, Inc.	33.37	33.37	0.71	1.89	0.34	0.04	NA	7.02
Salesforce Inc	53.49	53.49	1.46	10.04	0.1	0.05	0.0	61.43

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Enfusion Inc	Sell	$1.1B	-43.92%	277.75	1.7%
Shopify Inc.	Buy	$141.3B	135.8%	110.02	16.4%
Servicenow, Inc.	Buy	$226.3B	265.75%	170.58	12.77%
Intuit Inc.	Buy	$171.2B	115.56%	59.5	18.2%
Uber Technologies, Inc.	Buy	$142.6B	86.83%	33.37	10.49%
Salesforce Inc	Buy	$312.8B	84.06%	53.49	15.45%

About Enfusion

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Organization	Enfusion
Employees	1102
CEO	Mr. Oleg Movchan
Industry	Technology

Management People of Enfusion

Name	Title
Mr. Oleg Movchan	CEO & Director
Mr. Bradley Herring	Chief Financial Officer
Mr. Neal Pawar	Chief Operating Officer
Mr. Stephen Malherbe	Managing Partner
Ms. Valeria Gutowski	Chief Accounting Officer
Mr. Daniel Groman	Chief Technology Officer
Mr. Ignatius Tochukwu Njoku	Head of Investor Relations
Mr. Matthew R. Campobasso	General Counsel & Corporate Secretary
Ms. Bronwen Bastone	Chief People Officer
Mr. Joseph Defeo	Global Head of Managed Services Production

Important FAQs about investing in Enfusion (ENFN) from India :

What is Enfusion share price today?

Enfusion share price today stands at $11.11, Open: $11.16 ; Previous Close: $11.11 ; High: $11.20 ; Low: $11.06 ; 52 Week High: $11.38 ; 52 Week Low: $7.52. The stock opens at $11.16, after a previous close of $11.11. The stock reached a daily high of $11.20 and a low of $11.06, with a 52-week high of $11.38 and a 52-week low of $7.52.

Can Indians buy Enfusion shares?

Yes, Indians can invest in the Enfusion (ENFN) from India.

With INDmoney, you can buy Enfusion at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Enfusion at zero transaction cost.

How can I buy Enfusion shares from India?

It is very easy to buy Enfusion from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Enfusion be purchased?

Yes, you can buy fractional shares of Enfusion with INDmoney app.

What are the documents required to start investing in Enfusion stocks?

To start investing in Enfusion, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.